Indian-Origin Urologist Jitesh Patel Agrees to Pay $15.7 Million to Settle US Healthcare Fraud Allegations

In a major settlement that has sent ripples through the American medical community, Dr. Jitesh Patel, a prominent Indian-origin urologist practicing in Illinois, has agreed to pay $156 million (approximately ₹1,301.5 crore) to resolve allegations of healthcare fraud.

The settlement, announced by the U.S. Department of Justice this week, marks one of the largest fraud settlements involving an individual physician in recent years. Dr. Patel, who operated multiple urology clinics across Illinois, was accused of systematically billing federal healthcare programs for unnecessary medical procedures and tests spanning several years.

Federal investigators alleged that Patel’s practice routinely performed expensive diagnostic procedures on patients without proper medical justification. The investigation revealed a pattern of ordering comprehensive urological screenings for patients who presented with minor symptoms that could have been addressed with less invasive approaches.

“This settlement reflects our office’s commitment to protecting both patients and taxpayers from healthcare providers who put profits above patient care,” said the U.S. Attorney overseeing the case. “When physicians perform procedures that are not medically necessary, they not only waste taxpayer dollars but potentially subject patients to unnecessary risks.”

The case against Dr. Patel began three years ago when a former employee in his billing department filed a whistleblower complaint under the False Claims Act. This legislation allows private citizens to sue on behalf of the government and receive a portion of any recovered funds. The whistleblower, whose identity remains protected, is expected to receive approximately $28 million from the settlement.

Dr. Patel’s medical enterprise had grown substantially over the past decade, expanding from a single clinic to a network of urology centers throughout suburban Chicago and central Illinois. His practice became known for offering “comprehensive urological care,” advertising quick access to advanced diagnostic equipment. At its peak, his practice employed over 50 medical professionals and support staff across multiple locations.

According to court documents, the investigation focused particularly on billing patterns related to cystoscopies, urodynamic studies, and CT scans—procedures that carry significant reimbursement rates from Medicare and Medicaid. Authorities allege that Patel’s clinics performed these procedures at rates significantly higher than national averages for similar urology practices.

Healthcare fraud has remained a priority for federal prosecutors, with the Department of Health and Human Services estimating that improper payments cost Medicare and Medicaid billions annually. The settlement with Dr. Patel represents a significant victory in these ongoing enforcement efforts.

As part of the settlement agreement, Dr. Patel has also entered into a five-year integrity agreement with the Office of Inspector General. This requires his practice to implement substantial compliance measures, including regular external audits of billing practices and enhanced oversight of clinical decision-making.

Despite agreeing to the financial settlement, Dr. Patel has not admitted to any legal wrongdoing. Through his attorneys, he has maintained that the billing practices in question resulted from misunderstandings of complex coding requirements rather than intentional fraud.

“Dr. Patel has cooperated fully with the investigation and remains committed to providing quality urological care to his patients,” his attorney stated. “The decision to settle was made to avoid protracted litigation that would distract from patient care.”

The Illinois Medical Board is conducting its own review of the case to determine whether any additional professional sanctions are warranted. For now, Dr. Patel retains his medical license and continues to practice, though with enhanced oversight.

Healthcare policy experts note that this case highlights the ongoing tensions in American healthcare between fee-for-service reimbursement models and efforts to control costs. “When physicians are paid based on volume of procedures rather than outcomes, it creates problematic incentives,” said Dr. Eleanor Simmons, a healthcare policy researcher at Northwestern University.

The settlement funds will be returned to the Medicare and Medicaid programs, with a portion allocated to cover investigation costs and the whistleblower reward.